Product information and disease descriptionProduct descriptionProduct informationDosing and administration
Dosage
3 evidence topics · 4 sources
Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
Product information and disease descriptionProduct descriptionProduct informationDosing and administration
3 evidence topics · 4 sources